Cocaine Abuse and Attention Deficit Disorder - 3
Sponsor
National Institute on Drug Abuse (NIDA) (NIH)
Overall Status
Completed
CT.gov ID
NCT00000268
Collaborator
New York State Psychiatric Institute (Other)
32
1
42.1
0.8
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| N/A |
Detailed Description
To evaluate the safety and efficacy of methylphenidate and bupropion in treating individuals with adult Attention Deficit Disorder.
Study Design
Study Type:
Interventional
Allocation:
N/A
Intervention Model:
Single Group Assignment
Primary Purpose:
Treatment
Official Title:
Cocaine Abuse and Attention Deficit Disorder
Study Start Date
:
May 1, 1995
Study Completion Date
:
Nov 1, 1998
Outcome Measures
Primary Outcome Measures
- Side effects []
- Craving []
- Drug use []
- ADHD symptoms []
- Improvement in functioning []
- Tolerability []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
current adult ADHD current cocaine dependence
Exclusion Criteria:
no current major depression
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | New York State Psychiatric Institute | New York | New York | United States | 10032 |
Sponsors and Collaborators
- National Institute on Drug Abuse (NIDA)
- New York State Psychiatric Institute
Investigators
- Principal Investigator: Herbert Kleber, M.D., New York State Psychiatric Institute
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00000268
Other Study ID Numbers:
- NIDA-09236-3
- P50-09236-3
First Posted:
Sep 21, 1999
Last Update Posted:
Jan 12, 2017
Last Verified:
Nov 1, 2016
Keywords provided by ,
,
Additional relevant MeSH terms: